United States · FDA National Drug Code directory
Naproxen Sodium
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 58602-819_915208d0-ee3a-4b1f-9c3c-76d9cb8362c9
- Product NDC
- 58602-819
- Form
- TABLET, FILM COATED
- Composition / generic term
- Naproxen Sodium
- Labeler
- Aurohealth LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20171211
- Source listing expiry
- 20261231
Source-listed ingredients
- NAPROXEN SODIUM — 220 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 1 BOTTLE in 1 CARTON (58602-819-07) / 24 TABLET, FILM COATED in 1 BOTTLE · 58602-819-07
- 1 BOTTLE in 1 CARTON (58602-819-14) / 50 TABLET, FILM COATED in 1 BOTTLE · 58602-819-14
- 1 BOTTLE in 1 CARTON (58602-819-19) / 90 TABLET, FILM COATED in 1 BOTTLE · 58602-819-19
- 1 BOTTLE in 1 CARTON (58602-819-21) / 100 TABLET, FILM COATED in 1 BOTTLE · 58602-819-21
- 1 BOTTLE in 1 CARTON (58602-819-29) / 150 TABLET, FILM COATED in 1 BOTTLE · 58602-819-29
- 1 BOTTLE in 1 CARTON (58602-819-38) / 300 TABLET, FILM COATED in 1 BOTTLE · 58602-819-38
- 1 BOTTLE in 1 CARTON (58602-819-40) / 500 TABLET, FILM COATED in 1 BOTTLE · 58602-819-40
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →